Login / Signup

Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining.

Camille MorivalRichard WesterlynckGuillaume BouzilléMarc CuggiaPascal A Le Corre
Published in: European journal of clinical pharmacology (2017)
Different drug-drug interaction profiles were observed between statins with a higher prevalence of CYP3A4-based interactions for lipophilic statins. Analyzing the three most frequent DDIs, the more significant DDIs (level 1: contraindication) were reported for transporter-based DDI involving OATP1B1 influx transporter. These points are of concern to improve prescriptions of statins.
Keyphrases
  • cardiovascular disease
  • electronic health record
  • adverse drug
  • risk factors
  • clinical decision support
  • type diabetes